GC Biopharma (006280.KS), a leading global biopharmaceutical company, announced today that Ministry of Food and Drug Safety (MFDS) in South Korea has approved the Investigational New Drug (IND) ...

Vaccine expert Hu Haitao, who studied under Drew Weissman, the Nobel laureate and pioneer of mRNA biology, has given up his ...

Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research ...

A black-box warning is not a neutral informational update. It is the FDA’s most aggressive regulatory communication via product labeling, intended to alert clinicians and patients to risks so grave ...

Moderna will get $54M from a global coalition for a bird flu mRNA vaccine after the US canceled a $760M deal and cut mRNA ...

Since the announcements by federal health authorities earlier this year that federal mRNA vaccine funding will be curtailed, ...

Veritas In Silico Inc. ( ($JP:130A) ) has issued an update. Veritas In Silico has filed a substance patent application in Japan for a ...

Mount Sinai researchers developed a first-in-class cell-selective modRNA translation system that turns therapeutic genes on ...

Up to $54.3 million CEPI investment aims to help advance Moderna’s H5 pandemic influenza vaccine candidate to licensure Partnership strengthens global preparedness against a significant pandemic ...

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 7.8% in the afternoon session after the stock's ...

The co-founder of SCIMaP looks at the year of NIH cuts — and what they say about the future of American research.

Can the weakened immune systems of older individuals be rejuvenated? Researchers from the German Cancer Research Center (DKFZ ...